The 5 analysts offering 12-month price forecasts for ADC Therapeutics SA have a median target of 7.00, with a high estimate of 21.00 and a low estimate of 5.00. The median estimate represents a +94.99% increase from the last price of 3.59.
The current consensus among 6 polled investment analysts is to Buy stock in ADC Therapeutics SA. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.53
Reporting Date Mar 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.